Send this to a friend

Worcester biotech to treat bubble boy disease

The Worcester facility of New York biotech Mustang Bio will play a role in a new exclusive partnership with a leading children’s medical center to help develop treatments for an immunodeficiency disorder.
Mustang Bio, a subsidiary of Fortress Biotech, said Monday it has entered into an agreement with St. Jude’s Children’s Research Hospital in Tennessee to develop gene therapy treatments for X-linked severe combined immunodeficienc ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media